about
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus.A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populationsIRF5 polymorphism predicts prognosis in patients with systemic sclerosisSingle Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases.A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosisKCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorIndependent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosisImmunochip analysis identifies multiple susceptibility loci for systemic sclerosis.Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.Unraveling the genetic component of systemic sclerosis.Genetics of systemic sclerosis.Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways.An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators.Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis.HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping.Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort.Coloc-stats: a unified web interface to perform colocalization analysis of genomic features.A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediatorsA replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohortConfirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European populationGene expression variability across cells and species shapes innate immunityHistone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting[Genetics in scleroderma]Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis CohortChromatin activity at GWAS loci identifies T cell states driving complex immune diseasesGWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathwaysGNAI2 variants predict nonsteroidal anti-inflammatory drug hypersensitivity in a genome-wide studyLow RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosisCross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk
P50
Q29417125-C7DB2495-76A8-464A-962E-7A570A5696C9Q34577218-E0D03CE5-9557-40E2-B297-9C5B382CBF99Q35266391-1740AD72-B5B3-4382-BD95-636BAD4AFA52Q35816882-C0132741-FF2A-49EB-9D71-9723397072C1Q36032649-17863F2A-E88B-4FBE-BD29-58E7EA4EEEB2Q36094770-9E8EC19A-D80F-4C49-B765-BD02A488165EQ36245847-23DF87DD-40AC-4522-86E8-9EF4EEB48530Q36907640-F28ACEA7-C347-41D1-A975-1C19AA79549CQ36942326-25BC1FBA-58E0-4922-AEB9-BE2058735309Q37441841-671B793C-8DBB-464C-990C-403C0ADAC5B7Q37460616-88B4F761-16CE-4847-A347-E5CBB991A6BAQ37690304-61B2F74E-9F1C-432C-B30A-F83E23B3A1E6Q37973287-6FD114A3-13F8-49FD-B902-6D38B239FE4FQ38511454-D5C6A376-6C10-43CB-B037-AECEEF04761BQ38554821-C325DF6A-3FA4-48E6-BF44-3749514709C3Q38698316-68B4DFAF-475D-43D3-A0BB-9C0050D049D4Q39568339-66A62DCA-436C-47D4-BD37-C08CEAFA0979Q46089643-61C67C70-0B1E-4235-A112-80834ECAECB9Q48361487-8F8602AE-B5E2-4ECF-9FF0-ECAB982702C4Q48540998-88D0BF51-ABF0-48E7-A616-371824343A0FQ52862671-2A130830-3D16-4CA6-A1A5-4A53F8540C0BQ55461406-F438745F-E6F0-4965-AEF1-6C7E27E957F5Q55518777-0C104C99-577B-41F1-AFE2-11F16801DD6EQ57213592-E389CCB9-B4B5-40A9-AE51-FBCEEC616AFDQ57213592-EA2B1BDB-89B5-4D61-B3E1-B25130F0E0E9Q57306830-6CBC6F87-8B11-4198-82E8-77108194A7EEQ57307067-1AD964FA-88C4-4E00-A040-B652B764E632Q59071038-1AADDE6F-4C0C-46A3-AB60-DB1FF7848C2CQ63804680-23B565C0-2C90-45DF-A133-4354D90029B4Q84601494-773A5230-9C35-4821-97A9-17FAB680E007Q89901386-5B731EC9-E84F-47E2-9818-013272A2FADEQ90243369-4F18C51D-1867-4987-AB77-EEF8299D62E3Q91044925-04352EC9-C518-4C92-924E-171CA4CC129FQ91202596-0631F7D6-F092-4504-855F-BDECB9CD506AQ92281407-8AAB97AA-30EC-4511-A69E-2FCECC5DC45EQ92846950-AA42A190-63D5-4555-836F-8ADD16CD69A0
P50
description
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Lara Bossini-Castillo
@ast
Lara Bossini-Castillo
@en
Lara Bossini-Castillo
@en-gb
Lara Bossini-Castillo
@es
Lara Bossini-Castillo
@nl
Lara Bossini-Castillo
@sl
type
label
Lara Bossini-Castillo
@ast
Lara Bossini-Castillo
@en
Lara Bossini-Castillo
@en-gb
Lara Bossini-Castillo
@es
Lara Bossini-Castillo
@nl
Lara Bossini-Castillo
@sl
altLabel
Bossini-Castillo L
@en
prefLabel
Lara Bossini-Castillo
@ast
Lara Bossini-Castillo
@en
Lara Bossini-Castillo
@en-gb
Lara Bossini-Castillo
@es
Lara Bossini-Castillo
@nl
Lara Bossini-Castillo
@sl
P1053
G-1234-2016
P106
P31
P496
0000-0002-5471-5824